Arrowhead Pharmaceuticals Stock In The News
| ARWR Stock | USD 24.70 0.98 3.82% |
The overall news coverage of Arrowhead Pharmaceuticals from major news outlets shows bullish sentiment on 9 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Arrowhead Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Arrowhead Pharmaceuticals. The specific impact of Arrowhead Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Arrowhead Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Arrowhead Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Arrowhead Pharmaceuticals Backtesting and Arrowhead Pharmaceuticals Hype Analysis. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
Arrowhead |
Arrowhead Pharmaceuticals Today Top News and Investor Outlook
Arrowhead Pharmaceuticals Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Arrowhead and other traded companies coverage. We help investors stay connected with Arrowhead headlines for the 16th of April 2024 to make an informed investment decision based on correlating the impacts of news items on Arrowhead Stock performance. Please note that trading solely based on the Arrowhead Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.Arrowhead Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Arrowhead earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Arrowhead Pharmaceuticals that are available to investors today. That information is available publicly through Arrowhead media outlets and privately through word of mouth or via Arrowhead internal channels. However, regardless of the origin, that massive amount of Arrowhead data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Arrowhead Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Arrowhead Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Arrowhead Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Arrowhead Pharmaceuticals alpha.
Arrowhead Largest EPS Surprises
Earnings surprises can significantly impact Arrowhead Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-02-05 | 2019-12-31 | -0.01 | -0.03 | -0.02 | 200 | ||
2018-02-09 | 2017-12-31 | -0.16 | -0.18 | -0.02 | 12 | ||
2017-02-06 | 2016-12-31 | -0.2 | -0.17 | 0.03 | 15 | ||
2017-05-03 | 2017-03-31 | -0.12 | -0.08 | 0.04 | 33 | ||
2019-11-25 | 2019-09-30 | 0.16 | 0.11 | -0.05 | 31 | ||
2019-05-08 | 2019-03-31 | 0.19 | 0.24 | 0.05 | 26 |
Arrowhead Pharmaceuticals Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Arrowhead Pharmaceuticals Stock. Current markets are slightly bearish. About 56% of major world exchanges and indexes are down. See today's market update for more information.
3rd of April 2024
Disposition of 6000 shares by Hamilton James C of Arrowhead Pharmaceuticals at 28.03 subje... at news.google.com
20th of March 2024
Acquisition by Lu Hongbo of 1000 shares of Arrowhead Pharmaceuticals at 27.5 subject to Ru... at news.google.com
15th of March 2024
Disposition of tradable shares by Lu Hongbo of Arrowhead Pharmaceuticals subject to Rule 1... at news.google.com
8th of March 2024
Arrowhead Pharmaceuticals Initiates Phase 12a Study of ARO-DM1 for Treatment of Type 1 Myo... at businesswire.com
6th of March 2024
Disposition of 40000 shares by Kenneth Myszkowski of Arrowhead Pharmaceuticals at 35.19 su... at finance.yahoo.com
6th of February 2024
Arrowhead Pharmaceuticals GAAP EPS of -1.24 misses by 0.43, revenue of 3.55M misses by 26.... at seekingalpha.com
Arrowhead Pharmaceuticals Investors Sentiment
The influence of Arrowhead Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Arrowhead. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with an investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Arrowhead Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Arrowhead Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Arrowhead Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Arrowhead Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arrowhead Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arrowhead Pharmaceuticals' short interest history, or implied volatility extrapolated from Arrowhead Pharmaceuticals options trading.
Check out Arrowhead Pharmaceuticals Backtesting and Arrowhead Pharmaceuticals Hype Analysis. To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Arrowhead Stock analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.098 | Earnings Share (2.77) | Revenue Per Share 1.697 | Quarterly Revenue Growth (0.94) | Return On Assets (0.25) |
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.